Introduction
Inflammation is a complex response involving immune and stromal cells, triggered by tissue insults, such as infection, cancer and injuries. This response aims at removing or isolating the source of disturbance to allow the host to restore homeostasis. Central to the initiation and resolution of inflammation are cell populations of the myeloid lineage, particularly macrophages (M ). M reside in the ϕ ϕ tissues and can be secondarily differentiated from recruited blood monocytes. They are characterized by a high degree of functional plasticity dictated by a wide range of environmental cytokines and mediators, including pathogen associated molecular patterns , . As When inflammation-inducing conditions are sustained, the resulting chronic state can lead to the formation of a new structure, the granuloma, enriched in M and other immune cells. In this structure, M can further differentiate and acquire distinct morphologies . ϕ ϕ [3 ] Granulomas aid in the containment of otherwise uncontrollable pathogens and their destruction by T cells could be counter-productive for the host. Therefore, immunosuppressive mechanisms expressed by M , such as the amino acid degrading enzyme indoleamine 2,3 ϕ dioxygenase (IDO), are necessary to prevent excessive T cell activation . [4 ] We have recently shown that the immunosuppressive enzyme Interleukin-4 Induced Gene 1 (IL4I1) is expressed in various cancers by tumor-associated M , which are generally considered to belong to the M2 type , . Interestingly, Chu et al. first identified IL4I1 as a B ϕ [5 6 ] cell IL4-inducible gene and we also observed expression of the protein in several types of B-cell lymphomas , . Our initial work [5 7 ] identified the IL4I1 protein as a secreted L-phenylalanine oxidase that inhibits T cell proliferation through H O production . 2 2 [8 ]
In this report, we have characterized the conditions of IL4I1 expression by human myeloid cell populations and B lymphocytes in vitro in order to understand which local stimuli may induce IL4I1 expression in inflammatory lesions. We have confirmed that B cells are sensitive to IL4, but surprisingly observed that myeloid cell populations respond to activation of STAT1 by interferons, in accordance with IL4I1 expression in Th1 but not in Th2 granulomas. While STAT1 and STAT6 thus exert dichotomous effects on B lymphoid and myeloid cells, both cell types are sensitive to activation of NF B by proinflammatory stimuli.
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RESULTS
IL4I1 as a putative anti-inflammatory gene expressed by myeloid cells
We have previously reported that the purified IL4I1 enzyme was able to inhibit both CD4 and CD8 T lymphocyte proliferation + + in . This effect was dependent on the L-phenylalanine oxydase activity, in particular H O production whose toxicity affected vitro [8 ] 2 2 preferentially memory cells. In the current study, we have chosen the THP1 monocytic cell line to overexpress human IL4I1 (THP1-IL4I1), as we mainly detected IL4I1 expression in mononuclear phagocytes and , . IL4I1 activity in the in vitro in vivo [5 8 ] transfected cells was 895 363 pmoles H O /h/10 cells (mean from 5 independent tests) and the enzyme was secreted in the culture As THP1 represent immature monocytic cells, they were not able to stimulate efficiently allogeneic PBMC proliferation (less than 5000 cpm, data not shown) unless added together with soluble anti-CD3 antibody, which by binding THP1 Fc receptors may facilitate T cell receptor cross-linking. In these conditions, THP1 represented potent polyclonal stimulators. In contrast, THP1-IL4I1 cells used in the same conditions were significantly less efficient stimulators with 45. Proliferation inhibition did not result from enhanced apoptosis as measured by Annexin V/7AAD or activated caspase 3 labeling (data not shown), but was associated with a decreased IL2 secretion at day 1 ( 7 different experiments, ). However, proliferation p 0.015, . Since T cells were not purified from PBMC in the co-culture, we cannot exclude that some of the modifications in chemokine & F secretion were due to a cross talk between the affected T cells and monocytes. Indeed, when LPS-stimulated monocytes purified by -elutriation were cultured in conditioned media from THP1 and THP1-IL4I1 cells, no significant difference in their pattern of cytokine and chemokine secretion was observed, suggesting that IL4I1 does not directly regulate monocyte inflammatory properties (data not shown).
In conclusion, these results extend our previous data and suggest that IL4I1 may exert an immunoregulatory function in inflammatory conditions.
Granulomas represent chronic inflammatory lesions massively infiltrated by M -derived cells and DC. While sarcoidosis and ϕ tuberculosis are classically associated with Th1 responses, helminth infection, such as schistosomiasis generates Th2 granulomas. In order to confirm that myeloid cells are the main IL4I1 producers
and to explore what kind of cytokine milieu would favor IL4I1 in vivo expression in these cells, we selected for immunochemistry analysis, 6 cases of granuloma biopsies from patients with confirmed diagnosis of sarcoidosis, tuberculosis or schistosomiasis.
shows the results obtained for two representative cases of Th1 (granulomatous Figure 2 adenitis from a sarcoidosis) and Th2 (bladder schistosomiasis) lesions respectively. The Th1 granulomas are highly organized structures consisting primarily of activated macrophages typically in the form of epithelioid and giant multinucleated cells, mixed with DC and some T lymphocytes . In sarcoidosis and tuberculosis lesions, strong IL4I1 staining was detected in more than 80 of the granuloma cells, The structure of the granulomas in schistosomiasis is less organized than in Th1 lesions, with fewer giant cells. In contrast to the results obtained with tuberculosis and sarcoidosis, only very rare (<10 ) IL4I1-positive myeloid cells were detected in these granulomas % and when such cells were present, the specific staining was significantly less intense ( ). Fig. 2B These results suggest that a cytokine milieu rich in IFN might favor IL4I1 expression in M and DC . Our results were unexpected since IL4I1 has been originally described in B cells as an IL4-inducible gene . This led us to explore [7 ] in the level of IL4I1 activity in myeloid cells, i.e. monocytes, monocyte-derived DC and M , versus B cells after stimulation with IL4 vitro ϕ and IFN ( ). As already described, IL4 was able to induce a two-fold increase in IL4I1 activity in B lymphocytes, whereas IFN γ Fig. 3A γ did not have any effect. Conversely, IFN was a strong inducer of IL4I1 activity in all the myeloid populations, particularly in monocytes, γ which have a low basal activity (5 folds). No increase of IL4I1 activity in myeloid cells was observed in the presence of IL4, although we were not able to evaluate the IL4 effect on DC since this cytokine is necessary for their differentiation. However, only a minor induction of IL4I1 was observed after IL4 stimulation of purified circulating myeloid DC, whereas IFN confirmed its strong inducing effect on this spontaneously displayed IL4I1 activity and were not further stimulated by CD40L, despite still being responsive to IL4 ( ). Overall, reporter gene compared to TNF alone (data not shown). To improve the sensitivity of the assay and evaluate its performance, we α transfected STAT1 and STAT6 expressing vectors and compared the activation of the IL4I1-promoter region to the activation of reference promoters, TAP-1 and Bcl-xL respectively. After treatment with the corresponding cytokine and despite phosphorylation of the overexpressed STAT factors (data not shown), a minor induction of transcription from TAP-1 and Bcl-xL promoter could be induced. In these conditions, we could also observe a small induction of transcription from the IL4I1-promoter region when STAT1 was activated.
However, no consistent induction of the IL4I1-promoter could be measured after STAT6 activation ( ). These data indicate We had previously demonstrated that recombinant human IL4I1 coated on beads in a transwell system was able to inhibit CD3ζ expression leading to decreased CD4 and CD8 T cell proliferation. In this work, we have confirmed and extended these results by using + + a monocytic cell line constitutively expressing IL4I1 at similar levels to activated DC or M in order to mimic IL4I1 expression during an ϕ inflammatory reaction. In both polyclonal and antigen-specific conditions, we measured a significant decrease of T cell functions.
However, we could still measure residual T cell proliferation. This might be due to the presence of 1 mg/L of the oxygen radical scavenger glutathione in the RPMI 1640 culture medium, which could limit the toxic effect of H O produced by IL4I1 enzymatic activity. The 2 2 effect of IL4I1 activity would have probably been greater in the absence of this molecule, but was impossible to measure since T lymphocytes did not proliferate in glutathione-free classical medium (DMEM, data not shown).
In addition, the inhibition of IL2 production and T cell proliferation was accompanied by diminished secretion of IFN , IL1 and γ α proinflammatory chemokines. Since we did not observe a direct effect of IL4I1 on monocytes, the T cells which produce less IFN may γ instruct the monocytes present in the PBMC population to limit their chemokine production. Moreover, IL4I1 reaches its maximal expression in terminally differentiated M and DC, as has also been reported for the IDO enzyme , , , supporting a regulatory ϕ [4 13 14 ] function
[15 ]
, a particularly high expression of IL4I1 was observed in giant and epithelioid cells from chronic Th1 lesions, such as In vivo tuberculosis and sarcoidosis. This is in accordance with microarray data showing the induction of transcription in mouse lung by IL4I1 aerogenic infection with , . Interestingly, another immunosuppressive enzyme, IDO, has been detected Mycobacterium tuberculosis [16 17 ] in listeriosis and to a lesser extent in other granulomatous diseases, including sarcoidoisis and tuberculosis . Thus, expression of [4 ] immunosuppressive enzymes in chronic Th1 lesions could be a common regulatory mechanism induced at variable levels by different pathogens. Granulomas are known to assume two complementary functions: they limit the proliferation of bacteria and prevent their systemic spread. Therefore, two independent roles might be attributable to immunosuppressive enzymes in these structures.
(1) As suggested by Popov et al , local inhibition of destructive T cells could allow maintenance of the bacterial containment function. (2) At [4 ] the same time, the enzymatic activity could have an antibacterial role local consumption of essential amino acids and production of via toxic catabolites (H O for IL4I1 and kynurenine for IDO). We present evidence here that IL4I1 exert an inhibitory effect on T cell 2 2 functions. Preliminary experiments indicate that IL4I1 also inhibits bacterial growth (VMF and FC unpublished data).
In marked contrast to the observations made in Th1 granulomas, only faint and rare expression of IL4I1 was detected in Th2 lesions.
Indeed, we clearly demonstrated that IL4I1 expression in myeloid cell populations is insensitive to IL4, whether alone or in in vitro association with other stimuli. Only B cells produced IL4I1 in response to IL4, albeit to a dramatically lesser extent (more than 50 fold lower) than M or DC stimulated by interferons. This could explain why IL4I1 expression is not revealed by immunohistochemistry in the ϕ B cells present in Th2 lesions. We currently lack an explanation for this striking difference in cytokine sensitivity between B lymphocytes and myeloid cells. Both types of cells are equipped with STAT1 and STAT6, which can modulate some of their functions and in vitro in , , . Moreover, our bioinformatic analysis of the promoter region of IL4I1 confirmed the presence of STAT-binding vivo [1 18 19 ] consensus sites. In line with this, fludarabine, an inhibitor of STAT1 transcription, and a STAT6-specific siRNA inhibited IL4I1 production, in monocytic and B cell lines respectively. In mouse splenocytes, STAT6 has previously been shown to control IL4I1 transcription . However, we detected only small STAT1-and no STAT6-transcriptional activity on the putative IL4I1 promoter region [19 ] in the HEK293 cell gene reporter system. The minor induction of transcription from STAT1 and STAT6 promoters indicates that bona fide HEK293 cells are not optimal for the analysis of STAT promoter regions. Factors absent in epithelial cells may be necessary for the optimal transcriptional activation of IL4I1 by STAT proteins. These factors might be specific to mononuclear phagocytes and B lymphocytes, and regulate STAT signalling or associate with the STATs on the promoter. IL4I1
In addition to STAT1 and STAT6, we identified NF B as a key factor in IL4I1 expression that operates in both myeloid and B cells. . As for the STATs, the presence of additional factors specifically expressed by haematopoietic cells may be required to obtain [20 ] an optimal transcriptional effect. This hypothesis is supported by the observation that cancerous epithelial cells only very rarely express IL4I1 despite frequent association with an inflammatory context , . [5 21 ] Numerous pathogen-associated molecular patterns (PAMPs) activate the NF B pathway and in our hands, LPS, zymosan and polyIC In conclusion, our data demonstrate that myeloid cells from the mononuclear phagocyte lineage represent the major IL4I1 producing population and . In contrast to the B lymphocytes, IL4I1 activity in these cells is controlled by the interferon family of in vitro in vivo cytokines. By producing IL4I1 in response to STAT1 and NF B inducing stimuli, myeloid cells may play a major role in the regulation of κ chronic Th1 inflammation.
MATERIALS AND METHODS
Antibodies, cytokines and chemical inhibitors
Human recombinant IL4 (50ng/ml), IL6 (10ng/ml), IL10 (10ng/ml) and IL13 (50ng/ml) were purchased from R&D systems (Lille, France), LPS (20ng/ml), PGE (1 g/ml), polyIC (10 g/ml), zymosan (50 g/ml) and fludarabine (50 M) from Sigma Aldrich, human (clone L26), monoclonal anti-CD68 (clone KP1) were purchased from DAKO (Glostrup, Denmark); monoclonal anti-S100 (clone S100A2/1) from Labvision (Interchim, Montlu on, France), monoclonal anti-CD1a (clone 010) from Beckman Coulter (Marseille, purchased from eBioscience (San Diego, USA). Anti-RelA, RelB, cRel, p105/p50 and p100/p52 supershifting antibodies were purchased from Santa Cruz Biotechnology.
Cell culture and transduction
The hours later, and the incubation was prolonged for a total of 72 hours. Cells were then washed, and fresh medium was added. The culture was then continued as described above.
Plasmids, siRNA and transfection conditions
Human IL4I1 cDNA was cloned in pCDN3.1 myc-his (Invitrogen) as described in Boulland et al.
. Wild-type (WT) I B and [8 ] κ α S32A-S36A dominant negative mutants in a pCMV vector were purchased from Clontech Laboratories (Mountain view, CA, USA).
pTRIP-U3-EF1 -IRES GFP lentiviral vector for I B S32A-S36A mutant was a kind gift from M. Fontenay (Institut Cochin, Paris,
France). STAT6 cDNA cloned in pcDNA was described by Ritz et al and STAT1 cDNA cloned in pRC/CMV vector was purchased [24 ] α from Addgene (Addgene inc, Cambridge, MA, USA). Control (AAUUCUCCGUUCGUGUCACGU) or STAT6
(ACGGAUAGGCAGGAACAUACA)-targeting small interfering RNA (siRNA) were obtained from Qiagen (Courtaboeuf, France). TAP-1 and Bcl-xL luciferase reporter vectors were a kind gift from I. Dusanter, Institut Cochin, Paris . The THP1 monocytic cell line [25 ] and lymphoblastoid cell lines were nucleofected (Lonza, Germany) using the nucleofection kit V and the program L13 and O17
respectively. Stable THP1 cell lines expressing hIL4I1 (THP1-IL4I1) were selected with 0.75mg/ml of G418 (Invitrogen). IL4I1 activity of the THP1-IL4I1 cell lines was 895 363 pmoles H O /h/10 cells and was in the range of the activities measured on IFN stimulated M 
Enzymatic assay
IL4I1 enzymatic assay was performed as described in Carbonnelle-Puscian et al. using Amplex Ultra Red (Invitrogen, France) and [5 ] expressed as pmoles H O produced in the presence of phenylalanine per hour per 10 viable cells unless otherwise specified.
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Proliferation assays
All functional assays were performed in complete RPMI 1640 supplemented with 10 heat-inactivated human AB-serum. PBMC (2 % × 10 cells/well) stimulated with anti-CD3 (20ng/ml) were co-cultured 4 days in 96 well round bottom plates with 2.5 10 to 10 irradiated 7 14 Cytokine
Cytokine measurements
were measured with OptEIA ELISA kits from BD Biosciences (Le Pont de Claix, France) according to manufacturer s instructions.
'
Immunohistochemistry and immunofluorescence
IL4I1 immunohistochemistry on formol-fixed paraffin embedded thin sections was performed as described by Carbonnelle-Puscian et al.
. Images were captured with an Olympus BX40 microscope (Olympus, Tokyo, Japan). Photographs were taken with an Olympus [5 ] C-5060 camera. Images were processed with Adobe Photoshop v7.0 (Adobe Systems, San Jose, CA). Double immunofluorescence labeling of deparaffinated 3 5 m tissue slices was performed after antigen retrieval in citrate buffer pH 6 at 98 C for 30min. Mouse -μ =°p rimary antibodies were revealed using Alexa Fluor 488 conjugated anti-mouse antibodies (Molecular Probes, Invitrogen). IL4I1
antibodies were revealed using an anti-rabbit biotinylated antibody followed by a streptavidin-Texas Red. Photographs acquisition was performed with a Hamamatsu C8484 digital camera and Fluovision IMSTAR software. This study was approved by the French ethical committee Comit de Protection des Personnes Ile-de-France IX.
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Reporter assay
The 1Kb non-transcribed fragment in 5 of the coding sequence was analysed for putative transcription factor binding sequences 
Immunoprecipitation and Western blot
One ml of conditioned medium from THP1 or THP1-IL4I1 was immunoprecipitated by addition of 4.5 g of rabbit anti-IL4I1 μ antibodies overnight at 4 C followed by protein A/G sepharose (Santa Cruz, USA). After extensive washes, bound proteins were eluted [8 ] °i n SDS-PAGE loading buffer and separated by SDS-PAGE followed by transfer onto polyvinylidene difluoride membranes (Millipore, St
Quentin en Yvelines, France). Revelation was performed using the same specific primary antibody, followed by revelation using anti-rabbit HRP-conjugates and Enhanced Chemi Luminescence (GE ECL plus ) detection with the Autochemi System and Labworks ® Analysis Software (UVP, Cambridge, UK). For STAT1 Western blot, extracts containing similar amounts of proteins were migrated by SDS-PAGE as above and revealed after transfer by a rabbit polyclonal anti-STAT1 antibody (Cell signaling).
Electrophoretic Mobility Shift Assays (EMSA)
Nuclear extracts were prepared as in Pallard et al and analyzed for DNA binding activity using the HIV-LTR tandem B [26 ] κ oligonucleotide as B probe . For supershift assays, nuclear extracts were incubated with specific antibodies for 30 min on ice, before κ [27 ] incubation with the labeled probe.
Statistical analysis
Statistical analyses were performed using one-way Anova test followed by Bonferroni post-test or Wilcoxon matched paired t test.
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